Jon L. Collins - Concepedia

Author

Jon L. Collins

Also Known As

Collins, Jon L., J. Collins, J. L. COLLINS, J. L. Collins, J.L. Collins, Jon Collins, Jon L Collins, Jon L. Collins, Jon L. Collins, Redinbo, Matthew R.

104

Publications

13.2K

Citations

H-Index

Concepts

All Affiliations

Research Triangle Park Foundation GlaxoSmithKline (United States)GlaxoSmithKline (United Kingdom)GlaxoSmithKline (Netherlands)Howard Hughes Medical Institute

About

Jon L. Collins is an author at Research Triangle Park Foundation specializing in medicine, biochemistry, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	26	29	6.3K
2	Natural Sciences	20	23	3.8K
3	Engineering	9	9	392
4	Health Sciences	6	6	1.4K
5	Allergy	2	2	291

Jon L. Collins

Publications

12.9K

Citations

H-Index

Page 1

	Year	Citations
St. John's wort induces hepatic drug metabolism through activation of the pregnane X receptor Linda B. Moore, Bryan Goodwin, Stacey A. Jones, Proceedings of the National Academy of Sciences PharmacotherapyOxidative StressGastrointestinal Peptide HormoneMolecular PharmacologyPhytopharmacology	2000	936
Synthetic LXR ligand inhibits the development of atherosclerosis in mice Sean B. Joseph, Elaine McKilligin, Liming Pei, Proceedings of the National Academy of Sciences	2002	933
ApoE Promotes the Proteolytic Degradation of Aβ Qingguang Jiang, C.Y. Daniel Lee, Shweta Mandrekar, Neuron Alzheimer's DiseaseBiochemistryMedicineNatural SciencesCell Death	2008	854
Orphan Nuclear Receptors Constitutive Androstane Receptor and Pregnane X Receptor Share Xenobiotic and Steroid Ligands Linda B. Moore, Derek J. Parks, Stacey A. Jones, Journal of Biological Chemistry Pregnane X ReceptorSignal TransductionPxr Activator ClotrimazoleBiochemistryFunctional Selectivity	2000	808
Direct and Indirect Mechanisms for Regulation of Fatty Acid Synthase Gene Expression by Liver X Receptors Sean B. Joseph, Bryan Laffitte, Parthive H. Patel, Journal of Biological Chemistry	2002	760
The Human Nuclear Xenobiotic Receptor PXR: Structural Determinants of Directed Promiscuity Ryan E. Watkins, G. Bruce Wisely, Linda B. Moore, Science Proteinlipid InteractionPolar ResiduesGeneticsMolecular BiologyCholesterol-lowering Drug Sr12813	2001	748
Functional Consequences of Cysteine Modification in the Ligand Binding Sites of Peroxisome Proliferator Activated Receptors by GW9662 Lisa M. Leesnitzer, Derek J. Parks, Randy K. Bledsoe, Biochemistry	2002	558
Structural determinants of ligand binding selectivity between the peroxisome proliferator-activated receptors H. Eric Xu, Millard H. Lambert, Valerie G. Montana, Proceedings of the National Academy of Sciences	2001	529
Activation of liver X receptor improves glucose tolerance through coordinate regulation of glucose metabolism in liver and adipose tissue Bryan Laffitte, Lily C. Chao, Jing Li, Proceedings of the National Academy of Sciences	2003	493
Identification of a Nonsteroidal Liver X Receptor Agonist through Parallel Array Synthesis of Tertiary Amines Jon L. Collins, Adam M. Fivush, Michael A. Watson, Journal of Medicinal Chemistry Combinatorial ChemistryPharmacotherapyMolecular PharmacologyMedicinal ChemistryOxysterol	2002	426

Page 1